It is with great pride that the Control of Structure-Specific Endonucleases and Genome Stability team announces its accreditation for the period 2025-2029. This accreditation testifies to the quality and importance of the work carried out by the team in the fight against cancer, as well as to the confidence shown by the League.

Support from the Ligue Contre le Cancer enables the team to pursue its innovative research on the SLX4 tumour suppressor (“An integrated approach to dissect functions of the SLX4 tumour suppressor”).

The team would like to express its gratitude to the Ligue Contre le Cancer for its unfailing support, which is helping to speed up scientific advances and improve cancer care.